Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
March 26, 2007

EvoGenix Optimizes GSK Protein Product

  • EvoGenix successfully completed the first project in a collaboration with GlaxoSmithKline. EvoGenix thus received a milestone payment.

    EvoGenix utilized its protein optimization technology, EvoGene™, to develop improved versions of a protein product from the GSK pharmaceutical pipeline. The protein variants generated had improvements in affinity that exceeded the 20-fold goal specified in the agreement.

    GSK will be responsible for further development of the product, with EvoGenix eligible to receive additional milestone payments as the product progresses through the pipeline. EvoGenix is also set to earn royalties on product sales should it be approved and launched.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.